『The Biotech Brief』のカバーアート

The Biotech Brief

The Biotech Brief

著者: The HEII
無料で聴く

このコンテンツについて

We quickly breakdown the latest news in biotech. Fast Facts. Big Breakthroughs.Copyright 2025 All rights reserved.
エピソード
  • 5: Street Pricing, Corporate Cartels, and the Generic Drug Price War
    2025/07/09

    Southwest Airlines is taking generic drugmakers to court and accusing more than 20 companies of price fixing that inflated costs for millions of Americans, including its own employees. In this episode of The Biotech Brief, we unpack the lawsuit, the history of generic drug cartel behavior, and why drug developers (yes, even biotech innovators) should be paying close attention. This episode explores how drug pricing moves from boardroom strategy to national scandal.

    続きを読む 一部表示
    6 分
  • 4: Rebranding Vision
    2025/07/08

    Ocular Therapeutix is rebranding and repositioning. This episode of The Biotech Brief breaks down their plans for competing in the Wet AMD space, the company’s brand pivot to be more retina focused, and why this branding shift is more strategic than cosmetic.

    続きを読む 一部表示
    4 分
  • 3: Disappointing Data. Cosentyx Doesn’t Deliver in Giant Cell Arteritis
    2025/07/07

    Novartis’ blockbuster Cosentyx has hit a wall. In this episode of The Biotech Brief, we unpack the Phase 3 GCAptAIN trial results, where Cosentyx failed to show benefit for patients with giant cell arteritis. We explore what GCA is, why this label expansion mattered, and how the drug—once seen as a contender in this space—fell short. Plus, we look at the commercial implications, the competitive IL-6 landscape, and what this means for the future of Cosentyx and Novartis’ inflammatory disease pipeline.

    続きを読む 一部表示
    5 分

The Biotech Briefに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。